Cardiovascular Digital Twin Enters Multi-Center Retrospective Validation

Six hospitals complete 4,021 coronary CTA validation; 30-day MACE prediction calibration slope 0.94.

Cardiovascular digital twin technology enters multi-center retrospective validation phase, with data transparency improving.

Trial Design

Retrospective Cohort

Element	Content
Participating centers	6 tertiary hospitals
Sample size	4,021 coronary CTA cases
Time span	2019-2026
Follow-up	30-day MACE

Digital Twin Pipeline

Technical flow:

Coronary CTA images
    ↓ AI segmentation
Patient-specific 3D model
    ↓ Personalized boundary conditions
Personalized blood flow simulation
    ↓ Reduced-order solver
Plaque shear stress hotspots + Virtual stent deployment
    ↓
Risk assessment report

Key Results

Metric	Value	95%CI
Calibration slope	0.94	0.89-1.00
C-statistic	0.71	0.67-0.75
Brier score	0.18	0.15-0.21

Statistical Expert Warnings

Selection bias: Retrospective data may overestimate performance
Center effects: Different center equipment variations
Temporal bias: 2019 data may not represent current technology

This article is fictional medical technology news and does not constitute medical advice.

Disclaimer

Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.